Consolidated Balance Sheet

Cash and cash equivalents

846.6

980.8

Current financial assets

956.4

2,410.5

Trade accounts receivable

2,218.8

2,021.4

Inventories

1,618.8

1,474.2

Other current assets

425.8

360.7

Income tax receivables

137.8

109.8

Assets held for sale

–

27.1

6,204.2

7,384.5

Intangible assets

11,424.9

9,867.2

Property, plant and equipment

2,793.4

2,647.2

Non-current financial assets

90.7

77.8

Other non-current assets

77.6

105.5

Deferred tax assets

885.5

736.4

15,272.1

13,434.1

Total assets

21,476.3

20,818.6

Current financial liabilities

2,086.2

440.4

Trade accounts payable

1,403.8

1,364.1

Other current liabilities

723.2

1,134.5

Income tax liabilities

533.7

465.1

Current provisions

403.0

494.7

Liabilities directly related to assets held for sale

–

–

5,149.9

3,898.8

Non-current financial liabilities

1,937.0

3,257.5

Other non-current liabilities

7.2

5.6

Non-current provisions

1,004.0

1,011.1

Provisions for pensions and other post-employment benefits

1,196.1

910.9

Deferred tax liabilities

967.2

665.5

5,111.6

5,850.6

Equity capital

565.2

565.2

Reserves

9,453.8

9,341.1

Gains/losses recognized immediately in equity

1,141.5

1,113.7

Equity attributable to Merck KGaA shareholders

11,160.5

11,020.0

Non-controlling interests

54.4

49.2

11,214.9

11,069.2

Total liabilities and equity

21,476.3

20,818.6